Skip to main content

HIFU and MR-guided focused ultrasound, at the UK centres that actually do it.

Focused ultrasound converges harmless sound waves onto a target deep in the body and heats it above sixty degrees - no incision, no ionising radiation.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What HIFU and MR-guided FUS cost privately in the UK.

Indicative ranges across the UK centres we work with.

In short

£8,000–£15,000, day-case, home the same day.

Procedure Indicative range
MR-guided FUS - uterine fibroids £8,000–£15,000
MR-guided FUS - essential/Parkinson’s tremor £20,000–£30,000
MR-guided FUS - painful bone metastases £6,000–£12,000
HIFU - focal therapy for prostate cancer £15,000–£25,000
HIFU - adenomyosis or other soft-tissue targets £8,000–£18,000
Consultation and planning MRI £400–£900

Prices vary by centre, by scanner time, by which consultant leads the case, and by target size and complexity.

The problem

The right centre, the right modality, the right honest read.

Focused ultrasound is spectacular when the target and the patient fit. It is a poor choice when they do not. The problem is finding somebody who will tell you which of those two you are before you commit.

  • Not sure it is right for you?

    For some patients, radiotherapy, RFA or surgery is simply a better fit. We look at your imaging and say so honestly.

  • Want it done properly?

    A named consultant, a planning MRI that confirms the target is reachable, and multidisciplinary discussion before treatment.

When it helps

When focused ultrasound is a serious option.

The UK indications with the strongest evidence and centres actively treating patients - plus a note on the cosmetic devices that share the acronym but do something entirely different.

  • Localised prostate cancer

    Focal HIFU for men with intermediate-risk disease confined to one area - see our dedicated focal-therapy page.

  • Symptomatic uterine fibroids

    MR-guided FUS as an alternative to myomectomy or uterine artery embolisation, avoiding incision and preserving the uterus.

  • Essential or Parkinson’s tremor

    MRgFUS thalamotomy targeting the Vim nucleus - unilateral, incisionless, for medication-refractory tremor.

  • Painful bone metastases

    MR-guided FUS for palliative pain relief when radiotherapy has been exhausted or is not tolerated.

  • Adenomyosis

    An emerging MRgFUS indication for women with heavy, painful periods wishing to avoid hysterectomy.

  • Selected liver, kidney and pancreatic tumours

    Case-by-case use where the target is reachable and surgery or RFA is not preferred - often within a trial.

  • Surgery-averse or surgically unfit

    A non-invasive option for patients who cannot tolerate a general anaesthetic or want to avoid incisions.

  • Not for cosmetic “HIFU lifts”

    The low-power aesthetic devices marketed for skin lifting are not therapeutic ablation and are not what this page covers.

Modalities

HIFU and MRgFUS are a family, not one procedure.

The guidance modality (MRI or ultrasound) and the anatomical target dictate which platform is used and which UK centre can do it.

  • MR-guided FUS (MRgFUS)

    The transducer sits inside an MR scanner. Real-time thermometry maps the temperature at the target - the standard for tremor, fibroids and bone mets.

  • Ultrasound-guided HIFU (USgHIFU)

    A transrectal or bodyworn probe guided by ultrasound. Used for prostate focal therapy (Sonablate, Focal One) and selected soft-tissue targets.

  • MRgFUS thalamotomy

    Unilateral ablation of the Vim thalamic nucleus for tremor. NICE-recommended (TA950 / IPG733); NHS commissioning via NHS England SPS.

  • MRgFUS for fibroids (ExAblate)

    Day-case ablation of symptomatic fibroids (NICE IPG413). Uterus-sparing; fertility considerations are discussed but it is not first-line for women actively trying to conceive.

  • MRgFUS for bone-met pain

    Palliative ablation of the periosteal nerves around a painful bony deposit. Reduces opioid need and re-irradiation.

  • Focal HIFU for prostate cancer

    Focal treatment of the cancerous lobe or index lesion. NICE IPG756 (2023) supportive for suitable cases. See our focal-therapy page for detail.

  • Emerging and trial indications

    Adenomyosis, breast fibroadenoma, selected HCC/renal/pancreatic tumours, and neurological applications beyond tremor - often within research pathways.

  • Consultation only

    An honest read on whether focused ultrasound is a candidate for your case at all - and, if not, what the better route is.

Safety and recovery

What to expect afterwards - honestly.

Focused ultrasound is a well-tolerated day-case treatment. The risks are specific to each indication - the ones worth knowing about are collected here.

  • No incision, no ionising radiation

    The beam converges at depth without cutting skin or delivering radiation. Repeat treatment stays on the table.

  • Skin burn along the beam path

    Small first- or second-degree burns are the commonest side-effect. Careful skin preparation and beam angling minimise the risk.

  • Non-target thermal injury

    Bowel, nerves and muscle in the beam path can be injured. Careful planning MRI and dose control are the safeguards.

  • Incomplete ablation and recurrence

    Not every target is fully ablated at the first pass. Follow-up imaging looks for viable residual tissue and repeat treatment is possible.

  • Tremor-specific: dysaesthesia and gait

    Numbness, tingling, gait unsteadiness or mild dysarthria after MRgFUS thalamotomy are common early and usually settle within weeks.

  • Prostate-specific side-effects

    Urinary retention, mild incontinence and erectile changes can follow focal HIFU. Fully covered on the focal-therapy page.

  • Fibroid-specific: skin and sciatic

    Anterior abdominal-wall skin burn and rare posterior sciatic irritation are the fibroid-specific risks - screened for at planning MRI.

  • Long treatment time

    Larger targets take two to three hours in the scanner. Sedation and positioning matter more than for a standard MRI.

  • Red flags

    Fever, spreading pain, new weakness or heavy bleeding after ablation are not normal - call the centre or A&E the same day.

Reading your treatment note

Your treatment note in four parts. Read the last one first.

Whichever platform was used, the note the consultant sends you keeps to the same shape.

A UK consultant reviewing a patient’s focused-ultrasound treatment plan

A quiet reminder

Ablation language is precise and can read coldly - we translate it for you.

If you would like us to talk you through the note before your review, just ask.

  1. 01 Header

    Indication and modality chosen

    Why focused ultrasound was chosen - the diagnosis, the target, and whether MRgFUS or USgHIFU was used.

  2. 02 Technique

    Planning, guidance and dose

    The planning MRI findings, the guidance modality, sonications delivered, temperatures achieved and any real-time adjustments.

  3. 03 Findings

    Ablation volume and any complications

    The volume treated, coverage of the target, and any intra-procedure events such as skin heating or patient discomfort.

  4. 04 Impression

    Recovery, follow-up and next steps

    Read this first: expected recovery, when to return to work and exercise, and the imaging or clinical review that follows.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Cover for focused ultrasound varies by insurer and by indication - usually funded where NICE-supported and clinically indicated, otherwise self-pay.

Frequently asked

Everything we get asked about HIFU and MR-guided FUS.

Quick answers on what it is, which conditions it treats, where it is available in the UK, and what it costs.

  • What actually is HIFU?

    High-intensity focused ultrasound uses multiple ultrasound transducers to converge sound waves at a small target volume deep in the body - like sunlight through a magnifying glass. Temperatures above sixty degrees Celsius cause coagulative necrosis of the target while intervening tissue is spared.

  • How is MR-guided FUS different from HIFU?

    MRgFUS uses the same focused-ultrasound principle but performs the treatment inside an MR scanner. MR thermometry maps the temperature at the target in real time - a level of feedback ultrasound alone cannot provide. HIFU is the broader term; MRgFUS is the MRI-guided variant.

  • Which conditions is HIFU used for in the UK?

    Localised prostate cancer (focal HIFU), symptomatic uterine fibroids, painful bone metastases, and medication-refractory essential or Parkinson’s tremor (MRgFUS thalamotomy). Adenomyosis, breast fibroadenoma and selected liver, kidney and pancreatic tumours are emerging or trial-based.

  • Is HIFU the same as the cosmetic “HIFU facelift”?

    No. The aesthetic devices marketed as HIFU (for example Ultherapy) use very low-power ultrasound to tighten skin. They are not therapeutic ablation, do not destroy tumours or nerves, and are not what this page covers.

  • How much does focused ultrasound cost privately in the UK?

    Roughly £8,000–£15,000 for MRgFUS of uterine fibroids, £20,000–£30,000 for MRgFUS thalamotomy for tremor, £6,000–£12,000 for palliative bone-met treatment, and £15,000–£25,000 for focal HIFU of the prostate.

  • Where in the UK is MRgFUS available?

    A small number of tertiary centres - including Imperial College Healthcare, UCLH, Sheffield, Bristol and Preston - offer MRgFUS on the Insightec ExAblate platform. Focal HIFU for prostate is delivered on Sonablate or Focal One at Cromwell Hospital and a handful of other units.

  • Is HIFU available on the NHS?

    Yes, for specific indications. NHS England commissions MRgFUS thalamotomy for tremor via the Specialised Prostate & Neurology services route, and focal HIFU for prostate has NICE IPG756 supportive guidance. Access varies by region and clinical criteria.

  • What are the main risks?

    Skin burn along the beam path, non-target thermal injury (bowel, nerve, muscle), and incomplete ablation with the possibility of recurrence. Tremor patients can develop transient dysaesthesia or gait unsteadiness; prostate patients may have urinary or erectile side-effects - covered in more depth on the focal-therapy page.

Related treatments

Looking for something else?